Adjuvanted trivalent influenza vaccine study in infants: A randomised controlled trial to determine the kinetics of the functional genomic response In the 2012 influenza season, ADITEC…
The World Health Organization (WHO) has established advanced training courses on vaccine adjuvants and formulation, taking place at the Vaccine Formulation Laboratory (VFL) at University…
Happy New Year! The ADITEC project team wishes all partners, collaborators and those who are interested in our work, a very Happy New year! In…
Support for Vaccine Development Deadline: 30 Jan 2015 5:00 p.m. CET Anticipated Decision Date 8 April 2015 The High Impact project on Advanced Immunization Technologies…
The High Impact Project ADITEC, was launched in October 2011 to develop new vaccination strategies. The scope of the project, funded through the 7th Framework…
Brussels, 21 October 2014 “Vaccination is the medical intervention that had the greatest impact on mankind. New technologies are increasing the power of vaccines to…
New affiliated members ADITEC aims to produce new knowledge for the next generation of new human vaccines. This goal requires a multidisciplinary approach where diverse…
Partners of the ADITEC consortium are presenting the third course on adjuvants and vaccine formulation. Dates: 9-13 February 2015 Location: Vaccine Formulation Laboratory at University…
Support for Vaccine Development Deadline: 30 May 2014 5:00 p.m. CET Anticipated Decision Date 30 June 2014 Please forward this message to anyone who could…
Happy New Year The ADITEC project team wishes all partners, collaborators and those who are interested in our work, a very Happy New year! In…
You must be logged in to post a comment.